Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Do Cao

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annales D'Endocrinologie|January 31, 2016
Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancerC Do Cao, J-L Wémeau
Annales D'Endocrinologie|April 22, 2008
[Anaplastic thyroid carcinoma]J-L Wemeau, C Do Cao
Annales D'Endocrinologie|November 21, 2002
[Thyroid nodule, cancer and pregnancy]J L Wémeau, C Do Cao
Annales D'Endocrinologie|June 12, 2010
Chromogranin A assay in clinical practiceM d'Herbomez, C Do Cao, D Vezzosi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patientsE Baudin, C Do Cao, A F Cailleux, et al.
Annales D'Endocrinologie|October 2, 2007
Thyrotoxicosis revealing metastases of unrecognized thyroid cancer: a report on two casesF Faivre-Defrance, P Carpentier, C Do Cao, et al.
Annales D'Endocrinologie|September 7, 2010
Hypercalcitonemia revealing a somatostatinomaC Do Cao, A Mekinian, M Ladsous, et al.
Annales D'Endocrinologie|November 6, 2022
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithmsF Borson-Chazot, C Buffet, M Decaussin-Petrucci, et al.
Clinical Endocrinology|March 12, 2008
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?C Cardot-Bauters, E Leteurtre, L Leclerc, et al.
European Journal of Endocrinology|March 18, 2009
Merits and pitfalls of mifepristone in Cushing's syndromeF Castinetti, M Fassnacht, S Johanssen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annales D'Endocrinologie|January 31, 2016
Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancerC Do Cao, J-L Wémeau
Annales D'Endocrinologie|April 22, 2008
[Anaplastic thyroid carcinoma]J-L Wemeau, C Do Cao
Annales D'Endocrinologie|November 21, 2002
[Thyroid nodule, cancer and pregnancy]J L Wémeau, C Do Cao
Annales D'Endocrinologie|June 12, 2010
Chromogranin A assay in clinical practiceM d'Herbomez, C Do Cao, D Vezzosi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patientsE Baudin, C Do Cao, A F Cailleux, et al.
Annales D'Endocrinologie|October 2, 2007
Thyrotoxicosis revealing metastases of unrecognized thyroid cancer: a report on two casesF Faivre-Defrance, P Carpentier, C Do Cao, et al.
Annales D'Endocrinologie|September 7, 2010
Hypercalcitonemia revealing a somatostatinomaC Do Cao, A Mekinian, M Ladsous, et al.
Annales D'Endocrinologie|November 6, 2022
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithmsF Borson-Chazot, C Buffet, M Decaussin-Petrucci, et al.
Clinical Endocrinology|March 12, 2008
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?C Cardot-Bauters, E Leteurtre, L Leclerc, et al.
European Journal of Endocrinology|March 18, 2009
Merits and pitfalls of mifepristone in Cushing's syndromeF Castinetti, M Fassnacht, S Johanssen, et al.
Pageof 2